Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,336 | -28,636 | -4,208 | -14,185 | -10,500 |
| Depreciation Amortization | 19,380 | 19,282 | 95 | 382 | 285 |
| Accounts receivable | N/A | N/A | N/A | 556 | 550 |
| Other Working Capital | -2,116 | 1,354 | 25 | 170 | 89 |
| Other Operating Activity | 530 | 366 | 178 | 358 | -221 |
| Operating Cash Flow | $-16,542 | $-7,634 | $-3,910 | $-12,719 | $-9,797 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -62 | N/A | N/A | -52 | -44 |
| Investing Cash Flow | $-62 | $N/A | $N/A | $-52 | $-44 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 38,505 | 38,505 |
| Other Financing Activity | -20 | -13 | -6 | -39 | -30 |
| Financing Cash Flow | $-20 | $-13 | $-6 | $38,466 | $38,475 |
| Beginning Cash Position | 58,705 | 58,755 | 58,755 | 33,060 | 33,060 |
| End Cash Position | 42,131 | 51,108 | 54,839 | 58,755 | 61,694 |
| Net Cash Flow | $-16,624 | $-7,647 | $-3,916 | $25,695 | $28,634 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,542 | -7,634 | -3,910 | -12,719 | -9,797 |
| Capital Expenditure | -62 | N/A | N/A | -52 | -44 |
| Free Cash Flow | -16,604 | -7,634 | -3,910 | -12,771 | -9,841 |